Patterns of <scp>HIV</scp> viral suppression in a clinical trial evaluating a contingency management intervention

Toegel and her team ran a hospital trial with the adults living with HIV.

Half got usual care. The other half earned cash each time their blood showed an undetectable viral load.

Rewards started big, then got smaller and less often to save money.

The cash group reached undetectable virus faster and stayed there longer.

Even when checks shrank to every few months, suppression held steady.

Usual-care levels caught up later, but never stayed as stable.

Thrailkill et al. (2018) warned that rich early rewards can spark relapse later. Toegel’s data show the opposite: suppression held while rewards thinned. The difference? Thrailkill stopped rewards cold (extinction); Toegel faded them slowly.

Dykens et al. (1991) showed that money-like rewards can push drug use aside. Toegel proves the same trick works outside the lab and keeps working as pay shrinks.

Lea et al. (1977) found staff over-punish when no one watches. Toegel removed close watching too, yet behavior improved—because the reward was tied to biology, not staff judgment.

You can use cash or gift cards to speed up medical adherence. Start big, then stretch the gap between rewards. The client’s own lab result becomes the judge, so staff bias fades. Track viral load, medication blood levels, or even clinic attendance—any clear bio-marker works.